VistaGen Therapeutics
VTGN
VTGN
112 hedge funds and large institutions have $110M invested in VistaGen Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 22
3% less funds holding
Funds holding: 116 → 112 (-4)
34% less capital invested
Capital invested by funds: $168M → $110M (-$57.5M)
Holders
112
Holding in Top 10
2
Calls
$2.47M
Puts
$1.41M
Top Buyers
| 1 | +$4.09M | |
| 2 | +$2.6M | |
| 3 | +$2.34M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$726K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$615K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$1.63M | |
| 3 | -$1.46M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.24M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$633K |